Integrated analysis of circRNA- related ceRNA network targeting neuroinflammation in medial temporal lobe epilepsy

Bingzheng Gong1, Mian Li2, Ziru Wang3

  • 1The Second Affiliated Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian 271000, China.

Brain Research Bulletin
|February 25, 2024
PubMed
Abstract

Insights

Researchers identified a novel competing endogenous RNA (ceRNA) network targeting neuroinflammation in medial temporal lobe epilepsy (mTLE). This network, involving circRNA, miRNA, and mRNA interactions, offers a potential therapeutic target for drug-resistant mTLE.

Area of Science:

  • Neuroscience
  • Genomics
  • Molecular Biology

Background:

  • Medial temporal lobe epilepsy (mTLE) is a common form of epilepsy.
  • mTLE is often resistant to drug treatments, impacting patient quality of life.
  • Novel therapeutic strategies for mTLE are urgently needed.

Purpose of the Study:

  • To construct and analyze a competing endogenous RNA (ceRNA) network.
  • To identify therapeutic targets for neuroinflammation in mTLE.
  • To explore novel treatment approaches for drug-resistant mTLE.

Main Methods:

  • Utilized R package for transcriptome analysis of GSE186334 data.
  • Constructed ceRNA networks using public databases.
  • Validated key network components in a Sombati cell model.

Main Results:

  • Identified 649 differentially expressed mRNAs and 36 differentially expressed circRNAs in mTLE patients.
  • Screened 23 candidate mRNAs associated with neuroinflammation.
  • Constructed a hub ceRNA network with 3 mRNAs, 22 miRNAs, and 11 circRNAs.
  • Confirmed the regulatory role of hsa_circ_0005145 and hsa-miR-149-5p in targeting IL-1α.

Conclusions:

  • Identified a hub ceRNA network and a circRNA-miRNA-mRNA axis targeting neuroinflammation in mTLE.
  • This axis represents a potential therapeutic target for mTLE.
  • The findings may lead to novel treatment strategies for drug-resistant mTLE.

Related Concept Videos